Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Ascorbic acid may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Ascorbic Acid 200mg tablets are white to light yellow, circular flat faced bevelled edge uncoated tablets debossed with "V & 200" separated by breakline on one side and plain on other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. The tablets have diameter of 9.0 mm and thickness 3.20 mm.
Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible This medicine is available in HDPE container side effects not listed in this leaflet. You can also having child resistant white polypropylene cap report side effects directly via the Yellow Card with pack size of 100 tablets and aluminium-PVC/ Scheme at: www.mhra.gov.uk/yellowcard or PVDC white opaque blister pack of 28 tablets. search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you Not all pack sizes may be marketed. can help provide more information on the safety Marketing Authorisation Holder of this medicine. Flamingo Pharma (UK) Ltd. First Floor, Kirkland House,
e before taking this medicine. Ascorbic Acid Tablets Do not take these tablets if:
Ascorbic Acid Tablets Always take this medicine exactly as described in this leaflet or as the doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is: Adults, the elderly and children over 4 years For the treatment of scurvy: The usual dose is not less than 250 mg a day in divided doses, up to a maximum of 1000 mg a day for adults and children over 12 years, and up to a maximum of 500 mg a day for children 4 -11 years.
Other medicines and Ascorbic Acid Tablets Tell your doctor if you are taking, have recently If you take more tablets than you should taken or might take any other medicines including If you have taken a lot more tablets than you any medicines. You have bought yourself, should, speak to your doctor or pharmacist straight particularly any of the following: away or go to your nearest hospital casualty
260 mm
260 mm
25 mm
Package Leaflet: Information for the user
5 mm
5 mm
150 mm
Ascorbic Acid Tablets 11-15 Peterborough Road, HDPE containers: This medicinal product does not Harrow, Middlesex, require any special temperature storage conditions. HA1 2AX, United Kingdom. Keep the container tightly closed. Store in the Manufacturer original package to protect from moisture. Flamingo Pharma (UK) Ltd. Blister packs: This medicinal product does not The Bloc, 38 Springfield Way, require any special temperature storage conditions. Anlaby, Hull, HU 10 6RJ, Store in the original package to protect from United Kingdom. moisture. Product licence number Tablets which are supplied in bottles should be Ascorbic Acid 50 mg Tablets PL 43461/0043 used within 100 days of first opening. Ascorbic Acid 100 mg Tablets PL 43461/0044 Keep this medicine out of the sight and reach of Ascorbic Acid 200 mg Tablets PL 43461/0045 children. This leaflet was last revised in 02/2026 Do not use this medicine after the expiry date which is stated on the label. The expiry date refers to the last day of that month Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Ascorbic Acid Tablets contain The active ingredient is Ascorbic Acid. Ascorbic Acid is produced as tablets. Each tablet contains 50mg or 100mg or 200mg of Ascorbic Acid. This medicine also contains the following inactive ingredients: Lactose monohydrate, maize starch, microcrystalline cellulose, colloidal anhydrous silica, talc and stearic acid. What Ascorbic Acid Tablets look like and the contents of the pack: Ascorbic Acid 50mg tablets are white to light yellow, circular flat faced bevelled edge uncoated tablets debossed with "V50" on one side and plain on other side. The tablet have diameter is 5.50 mm. Ascorbic Acid 100mg tablets are white to light GSL
MPLLASCXXXXTBCOM FPLXXX303V01
25 mm
Like all medicines ascorbic acid can cause side effects, although not everybody gets them.
yellow, circular flat faced bevelled edge uncoated tablets debossed with "V & 100" separated by breakline on one side and plain on other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. The tablets have diameter of 7.0 mm and thickness 2.60 mm.
Ascorbic Acid 50 mg, 100 mg and 200 mg Tablets Ascorbic acid
Ascorbic Acid 100 mg Tablets comes as tablet containing 100mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Ascorbic Acid 100 mg Tablets is ascorbic acid.
This leaflet reproduces the patient information leaflet approved for Ascorbic Acid 100 mg Tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the treatment of Vitamin C deficiency including the treatment and prevention of scurvy.
Posology
Adults and children over 4 years:
Treatment: Not less than 250 mg daily in divided doses.
Maximum daily doses:
Adults and children over 12 years, 1000 mg.
Children 4 – 11 years, 500 mg.
The elderly:
As for adults. As the dietary intake of vitamin C may be less in the elderly, they are at greater risk of being deficient in this vitamin.
Method of administration
For oral administration.
Hypersensitivity to ascorbic acid or to any of the excipients listed in section 6.1.
Ascorbic acid should not be given to patients with hyperoxaluria.
Increased intake of ascorbic acid over a prolonged period may result in an increased renal clearance of ascorbic acid, and deficiency may result if the intake is reduced or withdrawn rapidly (see section 4.8).
Ascorbic acid may interfere with tests and assays for urinary glucose, giving false negative results with methods utilising glucose oxidase with indicator (e.g. Labstix, Tes-tape) and false positive results with neocuproin methods.
Estimation of uric acid by phosphotungstate or by uricase with copper reduction and measurement of creatinine in non-deproteinised serum may also be affected.
High doses of ascorbic acid may give false negative readings in faecal occult blood tests.
Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, glucose-galactose malabsorption should not take this medicine as it contains lactose.
Ascorbic acid may reduce the absorption of amphetamines.
Ascorbic acid may increase the oral absorption of iron.
Concurrent administration of ascorbic acid with desferrioxamine enhances urinary iron excretion. Ascorbic Acid may increase the risk of cardiovascular adverse effects when given with desferrioxamine. Ascorbic acid should be used with caution in patients receiving desferrioxamine and cardiac function should be monitored.
Concomitant administration of aspirin and ascorbic acid may interfere with absorption of ascorbic acid. Renal excretion of salicylate is not affected and does not lead to reduced anti-inflammatory effects of aspirin.
Concomitant administration of aluminium-containing antacids may increase urinary aluminium elimination. Concurrent administration of antacids and ascorbic acid is not recommended, especially in patients with renal insufficiency.
Co-administration with amygdalin (a complementary medicine) can cause cyanide toxicity.
Ascorbic acid may interfere with biochemical determinations of creatinine, uric acid and glucose in samples of blood and urine.
Pregnancy
For ascorbic acid no clinical data on exposed pregnancies are available.
Animal studies do not indicate direct or harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development. Pregnant women should exercise caution.
Breast-feeding
Ascorbic acid is excreted in breast milk. Though again caution should be exercised, no evidence exists suggesting such excretion is hazardous to the infant.
Fertility
No data available.
Ascorbic acid has no known effect on the ability to drive and use machines.
Large doses of ascorbic acid may cause diarrhoea.
Renal and urinary disorders:
Patients known to be at risk of hyperoxaluria should not ingest ascorbic acid in doses exceeding 1 gram daily, as there may be increased urinary oxalate excretion. However such a risk has not been demonstrated in normal, non-hyperoxaluric individuals. Ascorbic acid has been implicated in precipitating haemolytic anaemia in certain individuals with a deficiency of glucose-6-phosphate dehydrogenase.
Increased intake of ascorbic acid over a prolonged period may result in an increase in renal clearance of ascorbic acid, and deficiency may result if the intake is reduced or withdrawn rapidly. Doses of more than 600mg have a diuretic effect.
Reporting of suspected adverse reactions:
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms
At doses of over 3 grams per day unabsorbed ascorbic acid is chiefly excreted unmetabolised in the faeces. Absorbed ascorbic acid additional to the body's needs is rapidly eliminated. Large doses of ascorbic acid may cause diarrhoea and the formation of renal oxalate calculi. Symptomatic treatment may be required.
Ascorbic acid may cause acidosis or haemolytic anaemia in certain individuals with a deficiency of glucose 6-phosphate dehydrogenase. Renal failure can occur with massive ascorbic acid overdosage.
Management
General supportive measures should be employed as required.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Ascorbic Acid 100 mg Tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.